|
RAD51L1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.908200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.596200E-01 |
| Normal-vs-Stage2 |
8.579600E-01 |
| Normal-vs-Stage3 |
5.243200E-01 |
| Normal-vs-Stage4 |
8.755000E-01 |
| Stage1-vs-Stage2 |
6.520400E-01 |
| Stage1-vs-Stage3 |
3.148800E-01 |
| Stage1-vs-Stage4 |
7.944800E-01 |
| Stage2-vs-Stage3 |
7.136400E-01 |
| Stage2-vs-Stage4 |
7.783200E-01 |
| Stage3-vs-Stage4 |
4.257200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.631800E-01 |
| Normal-vs-AfricanAmerican |
5.629400E-01 |
| Normal-vs-Asian |
7.262000E-01 |
| Caucasian-vs-AfricanAmerican |
1.933170E-01 |
| Caucasian-vs-Asian |
6.739000E-01 |
| AfricanAmerican-vs-Asian |
2.871800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.103000E-01 |
| Normal-vs-Female |
7.469200E-01 |
| Male-vs-Female |
4.717200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
9.580400E-01 |
| Normal-vs-Extreme_Weight |
7.098400E-01 |
| Normal-vs-Obese |
6.330000E-01 |
| Normal-vs-Extreme_Obese |
5.594000E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.361000E-01 |
| Normal_Weight-vs-Obese |
5.551000E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.960200E-01 |
| Extreme_Weight-vs-Obese |
2.463400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.557800E-01 |
| Obese-vs-Extreme_Obese |
3.146800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.509200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.924400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.095400E-01 |
| Normal-vs-Age(81-100Yrs) |
9.724100E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.107600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.119700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.457100E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.008400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.279290E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.270100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.249600E-01 |
| Normal-VS-Type2 PRCC |
8.557400E-01 |
| Normal-VS-KIRP CIMP |
5.161200E-01 |
| Normal-VS-Unclassified PRCC |
8.205000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.907200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.252400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.032800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.724000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
9.990800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.997000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.013200E-01 |
| Normal-vs-N1 |
8.314800E-01 |
| Normal-vs-N2 |
5.461800E-01 |
| N0-vs-N1 |
9.290000E-01 |
| N0-vs-N2 |
1.480650E-01 |
| N1-vs-N2 |
3.890600E-01 |
|
|
